Objective: Low B-vitamin status and high levels of serum homocysteine are found in depressed inpatients, but results of population-based studies of this association are inconclusive. We investigated whether a low dietary intake of B 6-9-12 vitamins and high levels of serum homocysteine are associated with depressive symptoms in elderly men. Methods: The study sample included a total of 332 men aged 70-90 years who were free from cardiovascular diseases and diabetes at baseline in 1990. Depressive symptoms were measured with the Zung Self-rating Depression Scale at baseline in 1990 and dietary factors with the crosscheck dietary history method in 1985 and 1990. Serum levels of homocysteine were obtained in 1985. Multiple linear and logistic regression analyses were performed. Results: Dietary intake of folate (À1.19, 95% CI À2.03; À0.36) and vitamin B 6 (À2.09, 95% CI À2.92; À1.26) per standard deviation increase was associated with lower levels of serum homocysteine, while vitamin B 12 was not associated with serum homocysteine. Intake of folate, vitamin B 6 , vitamin B 12 and levels of serum homocysteine were not related to depressive symptoms. Conclusions: Our results do not support the hypothesis that a low dietary intake of B 6-9-12 vitamins and high levels of serum homocysteine are related to depression in healthy elderly men.
Introduction
A low status of folate, vitamin B 6 , vitamin B 12 (B 6-9-12 vitamins) and high levels of serum homocysteine may be related to depression. B 6-9-12 vitamins are co-enzymes and cofactors in the methylation of homocysteine to methione. Methionine is a precursor of S-adenosylmethionine (SAM) and a necessary factor for the production of monoamine transmitters. Low levels of monoamine transmitters are associated with depression (Bottiglieri et al., 2000) .
Support for the hypothesis that a low status of B 6-9-12 vitamins and high serum homocysteine levels are related to depression originated from studies that showed that major depression is associated with lower blood levels of folate and vitamin B 12 in psychiatric patients (Alpert et al., 2000) . In addition, depressed patients with low blood levels of folate had a poorer response to anti-depressive treatment (Fava et al., 1997) . These results suggest that low blood levels of B 6-9-12 vitamins may be involved in the etiology of depression.
Thus far, population-based studies have not been conclusive. Studies that investigated the association of blood levels of B 6-9-12 vitamins and homocysteine with depression in the elderly showed inconsistent results (Penninx et al., 2000; Tiemeier et al., 2002; Almeida et al., 2004; Hvas et al., 2004a; Sachdev et al., 2005; Williams et al., 2005) . Studies in middle-aged men found that dietary intake of folate was associated with fewer depressive symptoms and with a lower risk of developing depression (Tolmunen et al., 2003 (Tolmunen et al., , 2004a , while the intake of vitamin B 6 and B 12 was not associated with depressive symptoms (Tolmunen et al., 2003) . To our knowledge, no studies examined the association between dietary intake of B 6-9-12 vitamins, homocysteine levels and depressive symptoms in the elderly.
In the present study, we first investigated whether dietary intake of folate, vitamin B 6 and vitamin B 12 was associated with serum levels of homocysteine. Second, we determined whether dietary intake of folate, vitamin B 6 and vitamin B 12 and serum levels of homocysteine were related to depressive symptoms in elderly men. Data were used from the Zutphen Elderly Study, using a cross-sectional design, with data collected in 1985 and 1990.
Methods
The Zutphen Elderly Study The Zutphen Elderly Study is a population-based prospective cohort study on risk factors and health in elderly men. The study design and measurements have been described in detail elsewhere (Feskens et al., 1993) . In brief, it started in 1985 as a continuation of the Zutphen Study, the Dutch contribution to the Seven Countries Study (SCS) (Keys et al., 1980) and was extended with a new random sample of men of the same age, also living in Zutphen, but not belonging to the original cohort. In total, 939 men aged 65-84 years participated in the study. Data collection followed the international protocol used in previous surveys of the SCS (Keys et al., 1980) . In 1990, the second round of the Zutphen Elderly Study took place. In that round, measures of depression, functional status and self-rated health were added. Informed consent was obtained from all the study participants.
Dietary factors and homocysteine levels
Information on habitual food consumption was obtained with the crosscheck dietary history method, adapted to the Dutch situation (Bloemberg et al., 1989) , which has been described in detail elsewhere (Kalmijn et al., 1997) . In brief, both in 1985 and 1990, each participant was interviewed by a trained dietitian, if possible in the presence of the person who prepared the hot meal, about his average food consumption pattern in the two weeks before the interview. A checklist of foods and quantities of food bought per week was used to calculate and verify the participant's food consumption pattern. The energy intake and the intake of folate, vitamin B 6 and vitamin B 12 were calculated with corresponding Dutch food tables that contained updated information on folate (Konings et al., 2001) . Homocysteine was measured in non-fasting venous blood samples, collected at the examinations in 1985 and stored at À201C until determination in 1995 (Stehouwer et al., 1998) .
Depressive symptoms
Depressive symptoms were measured using the Self-rating Depression Scale (SDS), developed by Zung (1965) . This scale was developed to assess depression among patients admitted to a psychiatric hospital and has frequently been used in non-institutionalized elderly . The reliability of the SDS is reasonable in elderly men (Cronbach's a 0.75) (Kivela and Pahkala, 1986) and has been validated repeatedly with other questionnaires on depressive symptoms, such as the Center for Epidemiology Study Depression Scale (CESD) (r ¼ 0.69) (DeForge and Sobal, 1988) , the Geriatric Depression Scale (GDS) (r ¼ 0.59) (Dunn and Sacco, 1989) and the Hamilton Depression Scale (r ¼ 0.80) (Biggs et al., 1978) . The questionnaire contains 20 either positively or negatively formulated items, based on clinical diagnostic criteria commonly used to diagnose depressive disorders. The answers on those items are coded on a four-point Likerttype scale varying from 'none or sometimes' to 'most or always'. Positive items on the absence of depressive symptoms were recoded, so that a higher score indicated more depressive symptoms, with total scores ranging from 20 to 80. Men with more than two missing items were excluded from the analysis. If one or two items were missing, a mean score of the present items of the subject was calculated to replace the missing item(s). An index for the SDS was derived by dividing the sum of the answers by 80 times 100 (range 25-100), with a higher score indicating more depressive symptoms. The original cutoff values are no depressive symptoms (o50) versus mild, moderate and severe depressive symptoms (X50) .
Other variables
The self-administered questionnaire comprised questions on demographic characteristics, educational level, lifestyle habits, and past and current morbidity. Education was classified in years of education. Marital status was classified as living alone (yes versus no). Alcohol consumption was assessed in the dietary survey, expressed in grams per day and classified as users and non-users (Kromhout et al., 1990) . Data on supplemental use of B vitamins were collected and subjects were classified as users versus non-users of supplements of B vitamins. Participants were classified as current or nonsmokers. Body mass index (BMI) was calculated from weight and height (kg/m 2 ), which were measured while the participant was standing in light clothing without shoes. Physical activity was assessed with a self-administered validated questionnaire designed for retired men (Westerterp et al., 1992) . All types of activity with an intensity of more than 2 kcal energy expended per kg of body weight during 1 h were summed and expressed as minutes of total physical activity per week (min/week). Self-rated health was assessed with a single-item question: 'We would like to know what you think about your health, with four answer categories: (1) healthy, (2) rather healthy, (3) moderately healthy, (4) not healthy. For the analyses, self-rated health was categorized into healthy versus rather healthy versus moderately healthy or not healthy. A clinical history of chronic obstructive pulmonary disease (COPD) and cancer was based on a doctor's conclusion using questionnaire information and the results of the physical examination. Men were classified as having chronic disease if they had a positive history of COPD and/or cancer. Disability was measured using a standardized questionnaire about routine activities of daily living and has been described in detail elsewhere (Van Den Brink et al., 2003) . In brief, three domains were assessed, instrumental activities, mobility and basic activities. The participants were classified as being disabled on a certain item if they reported a need for help or were not able to perform that activity. Subjects were classified as having no, mild, moderate or severe disabilities following a hierarchical disability coding scheme (Hoeymans et al., 1996) . In the analyses, disability was categorized into three groups indicating no disability, mild disability and moderate to severe disability. To measure overall cognitive functioning, the MiniMental State Examination was used (Folstein et al., 1975) . This screening test includes questions on orientation to time and place, registration, attention and calculation, recall, language and visual construction. The maximum score is 30 points, with a higher score indicating a better cognitive functioning. For the analyses, a continous measure of cognitive functioning was used.
Study sample
Depressive symptoms were measured during the second round of the Zutphen Elderly study, where of the 718 men still alive in 1990, 556 men (77%) participated. Of these, 380 (68%) were free of cardiovascular diseases (CVD) and diabetes. We excluded 43 men with more than two missing items in the SDS as well as five men with missing values in covariates. Thus, a study sample of 332 men remained for analysis.
Data analysis
All micronutrients were adjusted for energy intake using the regression residual method (Willett et al., 1997) . Linear regression analysis was used to estimate the cross-sectional relationship between daily intake of B 6-9-12 vitamins (entered as a continous independent variables) and levels of serum homocysteine (entered as a continous dependent variable). For these analyses, we used the measures of B 6-9-12 vitamins and homocysteine in 1985. In the first model, we adjusted for age. In the second model, we additionally adjusted for BMI (kg/m 2 ), current smoking (no vs yes), coffee consumption (cups/day), alcohol consumption (yes vs no) and energy intake (kcal). Additional adjustment for supplemental use of B vitamins did not change the estimates.
Means and standard deviations (s.d.) were computed for continuous baseline variables, and medians and 10-90 percentiles for continous variables with a skewed distribution. Frequency distributions were given for categorical variables according to the presence or absence of depressive symptoms based on the cutoff score of 50. Differences between categories of depressive symptoms were tested with analysis of variance, Kruskal-Wallis (in case of skewed distribution) or w 2 test.
The risk of having depressive symptoms associated with dietary intake of B 6-9-12 vitamins and serum homocysteine levels was examined with logistic regression analysis. Presence or absence of depressive symptoms dichotomized at an SDS score of 50 was the dependent variable, and tertiles of dietary intake of B 6-9-12 vitamins and tertiles of homocysteine level were entered as independent variables. Since no data on homocysteine levels in 1990 were available, we used the levels from 1985. In the first model, we adjusted for age. In the second model, we additionally adjusted for years of education, living alone (yes vs no), physical activity (min/ week), energy intake (kcal), self-rated health (rather healthy vs healthy and moderately healthy or not healthy vs healthy), disability in activities of daily living (mild vs no and moderate or severe vs no) and cognitive functioning (continuously). Additional adjustments for BMI, current smoking, alcohol consumption, supplemental use of B vitamins and coffee consumption did not change the risks.
All analyses were performed with the SAS statistical software package, version 9.1.2 (SAS Institute, 2004) . Point estimates are given with corresponding 95% confidence intervals (CI).
Results
The average energy-adjusted daily intake of folate (194 mg; 797) was below the recommended daily intake of 300 mg, and the average intake of vitamin B 6 (1.65 mg; 70.30) was also lower than the recommended daily intake (1.8 mg). In contrast, the average intake of vitamin B 12 (5.34 mg; 73.14) was much higher than the recommended intake of 2.8 mg per day. Twenty-nine percent of the subjects had increased levels of serum homocysteine (X15 mmol/l).
Higher dietary intake of folate and vitamin B 6 was inversely associated with levels of homocysteine (per s.d. increase À1.19, 95% CI À2.03 to À0.36 and À2.09, 95% CI À2.92 to À1.26, respectively). Intake of vitamin B 12 was not related to levels of serum homocysteine (Table 1) .
The average depressive symptoms score was 42.6 (s.d. 710), which is low in comparison with the cutoff value for mild depressive symptoms (50-59). The prevalence of mild to severe depressive symptoms was 22% (14% mild, 7% moderate and 1% severe depressive symptoms). Table 2 presents the baseline characteristics of the study sample. Men with mild to severe depressive symptoms (X50) were less physically active, less educated, had a higher BMI, were more likely to live alone, reported a worse self-rated health, were more disabled in activities of daily living and had lower cognitive functioning scores in comparison to men with no depressive symptoms. Supplemental use of B vitamins did not differ between subjects with no or mild to severe depression. Intake of B 6-9-12 vitamins and levels of homocysteine for men who were excluded from the analyses owing to missing values in the SDS were comparable to that for the men in the study sample. Table 3 presents the odds ratios (OR) for depressive symptoms in relation to dietary intake of B 6-9-12 vitamins and levels of serum homocysteine. The intake of folate, vitamin B 6 and vitamin B 12 was not associated with depressive symptoms. Also, the levels of serum homocysteine were not associated with depressive symptoms.
Discussion
In the present study, dietary intake of folate and vitamin B 6 was inversely related with serum homocysteine levels, while the intake of vitamin B 12 was not associated with serum homocysteine levels. A low dietary intake of folate, vitamin B 6 or vitamin B 12 and high levels of serum homocysteine were not associated with depressive symptoms.
Before discussing the results, first, we will consider some aspects of the present study. A strength of this populationbased study is the use of the dietary history method to obtain information on the usual food consumption of the participants. This is a reproducible (Bloemberg et al., 1989) and valid dietary survey method (Block et al., 1986) , which reduces the possibility of misclassification. Second, we were able to investigate the dietary intake of several B 6-9-12 vitamins, besides homocysteine levels, in relation to depressive symptoms. Intake of B 6-9-12 vitamins, homocysteine levels and depressive symptoms MH Kamphuis et al Some methodological limitations of the current study also need to be considered. First, selective participation of healthier elderly respondents and exclusion of men with missing values from the baseline sample may, to some extent, have led to a dilution of the observed associations. However, intake of B 6-9-12 vitamins and levels of homocysteine did not differ for men who were excluded owing to missing values in the SDS, and is not likely to have biased the results. Second, we had only serum homocysteine values available in 1985 and information on depressive symptoms in 1990. Earlier studies showed that serum homocysteine levels measured 1 (r ¼ 0.85) to 3 (r ¼ 0.78) years apart correlated strongly (Clarke et al., 1998) . Therefore, we assumed that these homocysteine values measured in 1985 were also representative of the values in 1990. Third, although we hypothesized that a low intake of B 6-9-12 vitamins may lead to depressive symptoms, we were not able to determine the prospective relation between the intake of B 6-9-12 vitamins and depressive symptoms. As a result, we cannot exclude the possibility that depressive symptoms may lead to a low intake of B 6-9-12 vitamins owing to loss of appetite and decreased food consumption. Since energy intake was not materially lower in depressed subjects and we adjusted for intake of energy, reverse causality is less likely.
Our observation that dietary intake of folate and vitamin B 6 was inversely associated with levels of serum homocysteine agrees with the hypothesis that several B 6-9-12 vitamins are involved in the metabolism of homocysteine. In contrast, intake of vitamin B 12 was not associated with homocysteine levels. This could be due to malabsorption of vitamin B 12 in elderly people (Ho et al., 1999) . The intake of vitamin B 12 was high compared to the recommended daily intake, however; and it was comparable with the intake in another Dutch older population. In this latter study, a substantial part of the population had a deficiency of vitamin B 12 despite the high intake (van Asselt et al., 1998) . In addition, the results of a previous study on dietary intake of B 6-9-12 vitamins and levels of homocysteine in middle-aged men showed that intake of folate, vitamin B 6 and vitamin B 12 was associated with levels of homocysteine univariately; however, in the multivariate analyses, only dietary intake of folate was associated with levels of homocysteine (de Bree et al., 2001) . In addition, randomized controlled trials showed that use of B vitamin supplements lowered homocysteine levels (Toole et al., 2004; Bonaa et al., 2006) .
Our observation of no association between dietary intake of folate and depressive symptoms is in contrast to the results of a study carried out in middle-aged men from Finland, which showed an inverse relation between dietary intake of folate and depressive symptoms (Tolmunen et al., 2003 (Tolmunen et al., , 2004a ). An explanation why we showed no, or at best a very weak but imprecise, association between dietary intake of folate and depressive symptoms could be that the intake of folate was low compared to the recommended daily intake of folate in the Netherlands. This low intake may have decreased the power to detect an effect. In addition, it might be possible that the association between dietary intake of folate and depressive symptoms weakens with age. This agrees with the results of studies that investigated the association between blood markers of folate and depressive symptoms. Two studies in middle-aged samples showed that low folate status was associated with depressive symptoms and lifetime depressive disorder (Morris et al., 2003; Sachdev et al., 2005) . Two studies in the elderly did not find an inverse association between plasma folate and depression (Penninx et al., 2000; Hvas et al., 2004a) , and one study did find an association for Latin women, but not for men (Ramos et al., 2004) . In addition, one study in an older population did observe an inverse association between folate status and depression, but this was due to physical comorbidity and cardiovascular diseases (Tiemeier et al., 2002) .
In our study, dietary intake of vitamin B 6 was also not associated with depressive symptoms. The intake of vitamin B 6 was below the recommended daily intake, which could have diminished the power to find an association. Our results are, however, in line with findings of the study carried out in middle-aged men in Finland. In this study, the intake Intake of B 6-9-12 vitamins, homocysteine levels and depressive symptoms MH Kamphuis et al of vitamin B 6 was adequate, but they could also not disclose an association between dietary intake vitamin B 6 and depressive symptoms (Tolmunen et al., 2003) . In contrast, the results of a study on blood markers of vitamin B 6 and depressive symptoms did show an inverse association (Hvas et al., 2004a) . However, a recent review concluded that there was no treatment effect of vitamin B 6 for depression, except for hormone-related depression in women (Williams et al., 2005) . Our results on dietary intake of vitamin B 12 and depressive symptoms confirm the results of the study carried out in middle-aged men in Finland, which also showed no association between dietary intake of vitamin B 12 and depressive symptoms (Tolmunen et al., 2003) . Furthermore, in a randomized controlled trial in the elderly, treatment with vitamin B 12 was not associated with a decrease in depressive symptoms (Hvas et al., 2004b) . Remarkably, studies on the blood status of vitamin B 12 did show an inverse association between vitamin B 12 and depression in the elderly (Penninx et al., 2000; Tiemeier et al., 2002; Hvas et al., 2004a ). An explanation could be that dietary intake of vitamin B 12 may not be reflected in serum levels of vitamin B 12 , because we also showed that dietary intake of vitamin B 12 was not associated with homocysteine levels. Further studies should compare dietary intake of vitamin B 12 with the blood status of vitamin B 12 and their relation to depression.
Finally, we did not find an association between serum homocysteine levels and depression. Studies on blood levels of homocysteine and depression have shown inconsistent results (Penninx et al., 2000; Tiemeier et al., 2002; Almeida et al., 2004; Hvas et al., 2004a; Tolmunen et al., 2004b; Chen et al., 2005; Papakostas et al., 2005; Sachdev et al., 2005) . The results of one of these studies suggest that the association between homocysteine levels and depression could be confounded by cardiovascular morbidity (Tiemeier et al., 2002) . Two studies that did show a positive association did not account for prevalent CVD in the analyses (Almeida et al., 2004; Sachdev et al., 2005) . However, two other studies did find a positive association, independent of vascular status (Chen et al., 2005) or history of myocardial infarction (Tolmunen et al., 2004b) . In our study, men with prevalent CVD and diabetes at baseline were excluded, which may explain why we did not find an association between homocysteine levels and depressive symptoms.
In conclusion, our findings confirm that dietary intake of folate and vitamin B 6 is an important correlate of serum homocysteine levels. However, the results of the present study do not provide evidence that dietary intake of B 6-9-12 vitamins and levels of serum homocysteine are related to depression in the elderly.
